Milan Grofik

Martin, ZI 03601, Slovakia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Neuropsychiatric symptoms of chronic stress and pharmacist counseling.

Neuropsychiatric symptoms of chronic stress and pharmacist counseling.

Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti

Published: June 23, 2026

Bile Acid Dysregulation in Parkinson's Disease: Longitudinal Changes and Altered Metabolic Interactions.

Bile Acid Dysregulation in Parkinson's Disease: Longitudinal Changes and Altered Metabolic Interactions.

Journal: Biomolecules

Published: April 27, 2026

Downbeat Nystagmus and Saccadic Oscillations in Spinocerebellar Ataxia Type 27B: A 14-Month Follow-Up Case Report.

Downbeat Nystagmus and Saccadic Oscillations in Spinocerebellar Ataxia Type 27B: A 14-Month Follow-Up Case Report.

Journal: Case reports in neurology

Published: April 09, 2026

A Case Report of Reversible Mitochondrial Bioenergetic Dysfunction in PBMCs in Anti-GAD65-Associated Cerebellar Ataxia.

A Case Report of Reversible Mitochondrial Bioenergetic Dysfunction in PBMCs in Anti-GAD65-Associated Cerebellar Ataxia.

Journal: Cerebellum (London, England)

Published: April 03, 2026

Breathing pattern and its variability in the early Parkinson's disease.

Breathing pattern and its variability in the early Parkinson's disease.

Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

Published: March 16, 2026

Visual evoked potential abnormalities in spinocerebellar ataxia type 27B: a case report.

Visual evoked potential abnormalities in spinocerebellar ataxia type 27B: a case report.

Journal: Documenta ophthalmologica. Advances in ophthalmology

Published: March 09, 2026

Effect of Aminopyridines on Oculomotor Dysfunction in Anti-GAD Ataxia: A Brief Report.

Effect of Aminopyridines on Oculomotor Dysfunction in Anti-GAD Ataxia: A Brief Report.

Journal: Cerebellum (London, England)

Published: November 15, 2025

Oculomotor Abnormalities in Anti-Glutamic Acid Decarboxylase-Positive Stiff Person Syndrome.

Oculomotor Abnormalities in Anti-Glutamic Acid Decarboxylase-Positive Stiff Person Syndrome.

Journal: Neurology international

Published: September 29, 2025

Early parasympathetic dysfunction in Parkinson's disease: insights from information-theoretic analysis.

Early parasympathetic dysfunction in Parkinson's disease: insights from information-theoretic analysis.

Journal: Frontiers in network physiology

Published: August 05, 2025

Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early-Onset and Familial Parkinson's Disease.

Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early-Onset and Familial Parkinson's Disease.

Journal: Movement disorders clinical practice

Published: July 31, 2024

The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research.

The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research.

Journal: International journal of molecular sciences

Published: June 14, 2024

p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe.

p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe.

Journal: Research square

Published: June 10, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026